Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
Abstract Aims Elevated heart rate (HR) in heart failure (HF) is associated with worse outcomes, particularly in acute HF (AHF). HR reduction with ivabradine reduces cardiovascular events in HF patients with reduced ejection fraction. The present trial aimed to test the hypothesis that the early HR r...
Main Authors: | Yang Su, Teng Ma, Zeyu Wang, Bin Dong, Chenhui Tai, Hao Wang, Fenglei Zhang, Chunxi Yan, Wei Chen, Yawei Xu, Lei Ye, Gee Jun Tye, Sang‐Bing Ong, Jian Zhang, Dachun Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12997 |
Similar Items
-
The Biological Effects of Ivabradine in Cardiovascular Disease
by: Graziano Riccioni, et al.
Published: (2012-04-01) -
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01) -
Mid cristal atrial tachycardia and ivabradine: A Case Report
by: Debasish Das, et al.
Published: (2021-01-01) -
If Channel Inhibition - Ivabradine for the Treatment of Heart Failure
by: Giuseppe MC Rosano, et al.
Published: (2019-01-01) -
IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)